Christopher Stanley

Dr Christopher Stanley is a leading academic researcher in microvascular physiology and cardiovascular disease, currently serving as Group Lead at the Heart Research Institute (HRI) and Research Affiliate at the University of Sydney. His work focuses on vascular tone regulation, inflammation, and metabolic signaling in sepsis and pregnancy-related complications.

• Education: BSc in Pharmacology and Physiology (First Class Honours, Leeds Metropolitan University), PhD in Pharmacology (University of Nottingham, 2013)
• Former affiliations: University of Oxford (postdoctoral work), Victor Chang Cardiac Research Institute (2014-2020)

His research spans mitochondrial dysfunction in septic arteries, oxidised protein signaling, and novel metabolite identification in sepsis. Current projects include therapeutic strategies to restore vascular function in sepsis and cardiovascular disease.

Awarded multiple honors including the Society for Free Radical Research Young Investigator Award, Sydney Cardiovascular Symposium Rising Star Award, and British Pharmacological Society Competitive Travel Awards.